Diagnostic features: A relatively large lesion that is often greater than several adjacent lobules and is occasionally accompanied by angiectasis and/or spongiosis hepatis (cystic degeneration)
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for two distinct indications: treatment of type 2 diabetes mellitus (Mounjaro) and chronic weight management (Zepbound)
marketing is strictly prohibited until formal approval is granted by the European Commission
Protein knockdown was assessed by immunoblotting and qPCR for GPx1
You may start with a lower daily dose and increase as tolerated, breaking up the doses into 2-3 servings daily
Hu X, Fujimoto J, Ying L, Reuben A, Chen R, Chow CW, Canales JR, Sun W, Hu J, Parra Cuentas ER, Behrens C, Wu CJ, Swisher SG , Zhang J, Heymach J, Hong WK, Wistuba II, Futreal PA, Su D, Zhang J